Otogenic Central Skull Base Osteomyelitis With Retropharyngeal Extension: A Case Report

Regina Jacobo-Pinelli1, Jose Alberto Guerrero-Paz1, Juan Antonio Lugo-Machado1

  • 1Otolaryngology, Hospital de Especialidades No. 2 Instituto Mexicano del Seguro Social (IMSS), Ciudad Obregón, MEX.

Cureus
|April 13, 2022
PubMed

Insights

Skull base osteomyelitis (SBO) is a severe infection often diagnosed late. Antimicrobial resistance in pathogens like E. coli can complicate treatment and worsen patient prognosis.

Area of Science:

  • Infectious Diseases
  • Otolaryngology
  • Neurosurgery

Background:

  • Skull base osteomyelitis (SBO) is a serious infection, particularly in patients with comorbidities.
  • Otogenic infections can spread through skull base fissures, leading to SBO.
  • Diagnosis is often delayed due to non-specific initial symptoms like headache.

Observation:

  • A case of otogenic SBO with retropharyngeal extension is presented.
  • The patient was treated with surgical drainage and broad-spectrum antibiotics targeting ESBL-producing E. coli.
  • The infection recurred three months post-treatment.

Findings:

  • Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli can cause recurrent SBO.
  • Antimicrobial resistance poses a significant challenge in managing SBO.
  • Successful treatment may be hindered by resistant bacterial strains.

Implications:

  • Highlights the critical role of antimicrobial stewardship in managing SBO.
  • Emphasizes the need for early diagnosis and appropriate antibiotic selection.
  • Underscores the impact of antimicrobial resistance on patient outcomes in SBO.